Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Capillary Electrophoresis Method Development – V 2.0

Posted on By

Analytical Method Development: SOP for Capillary Electrophoresis Method Development – V 2.0

Standard Operating Procedure for Capillary Electrophoresis Method Development in Pharmaceutical Analysis


Department Analytical Method Development
SOP No. SOP/AMD/170/2025
Supersedes SOP/AMD/170/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines a systematic approach for the development and validation of Capillary Electrophoresis (CE) methods used in the separation, identification, and quantification of charged pharmaceutical compounds,

impurities, and degradation products.

2. Scope

This procedure is applicable to the Analytical Method Development (AMD) department for CE method development in raw materials, APIs, and drug products where traditional chromatographic methods may be limited or less effective.

3. Responsibilities

  • Analytical Scientist: Responsible for method development, buffer optimization, and parameter tuning.
  • CE Instrument Operator: Conducts routine operation and maintenance of the CE system.
  • QA Officer: Reviews the method validation report and ensures regulatory compliance.
  • Head – AMD: Approves the final method and oversees its application in routine analysis.
See also  Analytical Method Development: SOP for Identification of Preservatives in Multi-Dose Vials - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the scientific integrity and regulatory compliance of CE-based analytical methods.

5. Procedure

5.1 Method Design and Planning

  1. Determine analyte properties: charge, pKa, polarity, UV absorbance.
  2. Select CE mode:
    • Capillary Zone Electrophoresis (CZE)
    • Micellar Electrokinetic Chromatography (MEKC)
    • Capillary Gel Electrophoresis (CGE)
  3. Choose appropriate detection system (e.g., UV, DAD, LIF).

5.2 Buffer System Optimization

  1. Select background electrolyte (BGE) buffer based on analyte pKa (e.g., phosphate, borate, acetate).
  2. Adjust buffer pH to optimize migration and resolution (target pH range: 2.5 to 9.0).
  3. Maintain buffer ionic strength at 10–50 mM to avoid excessive current.
  4. Filter and degas all solutions before use.

5.3 Capillary Conditioning and Instrument Setup

  1. Flush capillary with:
    • 0.1 N NaOH for 10 minutes
    • Water for 5 minutes
    • Buffer for 10 minutes
  2. Use a fused silica capillary (e.g., 50 µm ID, 60 cm total length, 50 cm effective length).
  3. Set voltage: 20–30 kV; temperature: 20–25°C; injection: pressure or electrokinetic.
See also  Analytical Method Development: SOP for DLS Method for Nanoparticle Size Analysis - V 2.0

5.4 Sample Preparation

  1. Prepare standard and test solutions in water, methanol, or buffer as appropriate.
  2. Filter samples through 0.22 µm membrane filter.
  3. Keep final concentration within 0.1–1.0 mg/mL.

5.5 System Suitability

  1. Inject system suitability mixture containing analyte and known impurities.
  2. Evaluate:
    • Resolution (Rs ≥ 1.5)
    • Theoretical plates (≥ 50,000)
    • Repeatability of migration time (RSD ≤ 2%)
  3. Record in Annexure-1: System Suitability Log.

5.6 Method Validation

  1. Validate per ICH Q2(R2):
    • Specificity – Distinct migration times for all analytes
    • Linearity – R² ≥ 0.995 across 50%–150% range
    • Accuracy – Recovery between 95%–105%
    • Precision – RSD ≤ 2% for peak area and migration time
    • LOD/LOQ – Based on S/N ratio (3:1 and 10:1)
  2. Summarize in Annexure-2: Method Validation Report.

5.7 Data Processing and Reporting

  1. Use appropriate software for data integration and peak quantification.
  2. Use area normalization or calibration curve method as applicable.
  3. Archive raw data, processed files, and final reports in controlled storage.

6. Abbreviations

  • CE: Capillary Electrophoresis
  • CZE: Capillary Zone Electrophoresis
  • MEKC: Micellar Electrokinetic Chromatography
  • BGE: Background Electrolyte
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • SOP: Standard Operating Procedure
See also  Analytical Method Development: SOP for Headspace GC Method Development - V 2.0

7. Documents

  1. System Suitability Log – Annexure-1
  2. Method Validation Report – Annexure-2
  3. CE Run Logbook – Annexure-3

8. References

  • ICH Q2(R2) – Validation of Analytical Procedures
  • USP <1053> – Biotechnology-derived Articles—Capillary Electrophoresis
  • Ph. Eur. 2.2.47 – Capillary Electrophoresis

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: System Suitability Log

Parameter Result Acceptance Status Analyst
Resolution 1.8 ≥ 1.5 Pass Sunita Reddy
Migration Time RSD 1.4% ≤ 2% Pass Sunita Reddy

Annexure-2: Method Validation Report

Parameter Result Criteria Status
Linearity R² = 0.997 ≥ 0.995 Pass
Recovery 98.5% 95%–105% Pass

Annexure-3: CE Run Logbook

Run ID Sample ID Migration Time (min) Peak Area Analyst
CE2025-011 API-B34 5.46 42873 Rajesh Kumar

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated buffer system and added CE Run Logbook Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Biosimilars: SOP for Media Filtration Before Use – V 2.0
Next Post: Gel Manufacturing: SOP for Sampling Gels for Stability Testing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version